ABO-CoV 617 2

N/A

Report date: 2023/08/18 20:01:02

Base Information

Drug NameABO-CoV 617 2
Drug Alias NameABO-CoV 617 2ABO-CoV.617.2COVID-19 vaccine(Abogen Biosciences Co Ltd)SARS-CoV-2 vaccine(Abogen Biosciences Co Ltd)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbogen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbogen Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A